Dr. Mitchell S. Cairo, MD

  • Valhalla, NY
  • Pediatric hematology and oncology physician
NPI1669446399
Publications
324
Clinical trials
40
Hospital affiliations
1
Industry payments
$1.4M
Medical group
1
Practice address
100 Woods Rd, Valhalla, NY 10595
Practice phone
Call (914) 493-7000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Westchester Medical Center

Hospital · Valhalla, New York

See all 3 affiliations

Find Dr. Cairo's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mitchell S. Cairo is a pediatric hematology and oncology physician in Valhalla, New York

Dr. Cairo practices at Westchester Medical Center in Valhalla, New York, part of Westchester Medical Center Health Network.

Dr. Cairo's NPI, 1669446399, was assigned on February 17, 2006. Dr. Cairo graduated from UCSF School of Medicine in 1976. Dr. Cairo's New York license number on file is 217898.

NPI and contact details
NPI enumeration date
February 17, 2006
NPI status
Active
Practice phone
(914) 493-7000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
76
Medical school graduation
1976

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data

Dr. Mitchell S. Cairo practices at Westchester Medical Center in Valhalla, New York

Dr. Cairo's primary practice is Westchester Medical Center, at 100 Woods Rd, Valhalla, NY 10595 in Westchester County. The practice phone is (914) 493-7000.

Source: Dmand AI Affiliation Data

Dr. Mitchell S. Cairo is affiliated with 2 sites of care and 1 medical group

Dr. Cairo's primary practice is Westchester Medical Center in Valhalla, New York, part of Westchester Medical Center Health Network. The medical group on file is Boston Children's Health Physicians. Dmand AI also links Dr. Cairo to 1 more group practice or clinic, named with a free account.

See all 3 affiliations for Dr. Cairo

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mitchell S. Cairo's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cairo practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Westchester Medical CenterAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Cairo practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Westchester Medical Center Health Network and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mitchell S. Cairo is one of 232 pediatric hematologys and oncology physicians in New York

Pediatric hematology-oncology is Dr. Cairo's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Cairo is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Cairo's licenses on file in 5 states: New York, California, Florida, District of Columbia and Indiana.

Specialties and state licenses

  • Pediatric hematology and oncology, New YorkPrimaryLicense 217898 · 2000 to 2025 · taxonomy 2080P0207X
  • California license1977 to 2026
  • Florida license2021 to 2023
  • District of Columbia license1998 to 2004
  • Indiana license1979 to 1982

Pediatric hematologys and oncology physicians near Dr. Cairo

Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mitchell S. Cairo's patients have a median age of 40

Across all payers, Dmand AI patient panel data puts Dr. Cairo's median patient age at 40, with 40% women.

Dr. Cairo's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 40

Patient panel by sex, all payers

  • Women40%
  • Men60%

Source: Dmand AI Patient Panel Data

Dr. Mitchell S. Cairo has 324 publications on record

Dmand AI links 324 papers to Dr. Cairo, published from 2003 to 2025. 2019 was the busiest year, with 11. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation Conditioning and Transplantation, Homologous. Dr. Cairo has published most often in Br J Haematol. Dr. Cairo's most frequent co-authors are Prakash Satwani, MD, James Garvin and Monica Bhatia.

Papers324
Years published2003 to 2025

Dr. Cairo's papers by year, 2016 to 2025

Topics Dr. Cairo writes about most

  • Hematopoietic Stem Cell Transplantation
  • Transplantation Conditioning
  • Transplantation, Homologous
  • Antineoplastic Combined Chemotherapy Protocols
  • Graft vs Host Disease
  • Fetal Blood
  • Neutrophils
  • Recombinant Proteins

Dr. Cairo's most frequent co-authors

Recent publications by Dr. Cairo

See all 324 publications and co-authors

See who Dr. Cairo researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Cairo works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mitchell S. Cairo has worked on 40 clinical trials

Dmand AI links Dr. Cairo to 40 clinical trials, 21 of them phase 2 studies. 17 are still active or recruiting. Conditions studied include Hodgkin Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma and Primary Immunodeficiency Diseases. New York Medical College sponsors the most, 28. Open Payments lists research payments to Dr. Cairo that name 2 trials.

Clinical trials with Dr. Cairo by phase

  1. 1Early phase 1: 1 trial
  2. 8Phase 1: 8 trials
  3. 5Phase 1/2: 5 trials
  4. 21Phase 2: 21 trials
  5. 3Phase 3: 3 trials
  6. NonePhase 4: no trials

Conditions in Dr. Cairo's trials

  • Hodgkin Disease
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Primary Immunodeficiency Diseases
  • Anemia, Sickle Cell
  • Dendritic Cell Sarcoma, Interdigitating

Investigators on the most trials with Dr. Cairo

Recent clinical trials with Dr. Cairo

See all 40 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Mitchell S. Cairo received $1,364,390 in industry payments from 2016 to 2025

CMS Open Payments shows 1,094 general payments to Dr. Cairo from 29 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 39% of the total. Jazz Pharmaceuticals Inc. paid the most, $499,700. It also lists 12 research payments totaling $25,475 from 2018 to 2025, naming 2 clinical trials.

General payments to Dr. Cairo by program year, 2016 to 2025

General payments to Dr. Cairo by kind, 2016 to 2025

$1.4Min total
  • Speaker and faculty fees$520,23739%
  • Consulting fees$493,18237%
  • Travel and lodging$130,53010%
  • Compensation for serving as faculty or as a speaker for a medical education program$122,7409%
  • Other$82,5846%

Companies that paid Dr. Cairo the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Cairo

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mitchell S. Cairo has 5 awards and honors on record

Dmand AI lists 5 awards for Dr. Cairo, most recently America's Top Doctors in 2014.

Awards and honors for Dr. Cairo

  1. 2014
    • America's Top Doctors
    • Top Doctors: New York Metro Area
  2. 2013
    • America's Top Doctors for Cancer
    • New York Magazine: Top Doctors
    • Westchester Magazine: Top Doctors

Source: Dmand AI Professional Profile Data

Dr. Mitchell S. Cairo graduated from UCSF School of Medicine

Dr. Cairo graduated from UCSF School of Medicine in 1976. Dr. Cairo is a member of AAP, AACR and ASCO.

  1. Medical schoolUCSF School of Medicine
  2. Board certified in pediatric hematology-oncologyAmerican Board of Pediatrics
  3. Board certified in pediatricsAmerican Board of Pediatrics

Source: Dmand AI Professional Profile Data

Dr. Mitchell S. Cairo accepts plans from 11 insurance carriers

Dr. Cairo is in network with 11 carriers, including MVP Health Care, United Healthcare and Elevance. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.

Plan types Dr. Cairo accepts, by number of carriers

  1. HMO8
  2. PPO6
  3. POS4
  4. Medicaid3
  5. EPO2
  6. Medicare1

Source: Dmand AI Insurance Network Data

Sources for Dr. Mitchell S. Cairo's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mitchell S. Cairo

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mitchell S. Cairo's NPI number?

Dr. Mitchell S. Cairo's NPI number is 1669446399. It was assigned on February 17, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Mitchell S. Cairo?

Dr. Mitchell S. Cairo is a pediatric hematology and oncology physician in Valhalla, New York. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).

Where does Dr. Mitchell S. Cairo practice?

Dr. Cairo practices at 100 Woods Rd, Valhalla, NY 10595. Dr. Cairo's primary practice is Westchester Medical Center in Valhalla, New York, part of Westchester Medical Center Health Network. Dmand AI also links Dr. Cairo to 1 group practice or clinic.

What is Dr. Mitchell S. Cairo's office phone number?

The practice phone on file for Dr. Cairo is (914) 493-7000.

What is Dr. Mitchell S. Cairo's medical license number?

Dr. Cairo's New York license number on file is 217898, one of the licenses on file in 5 states.

Which states has Dr. Mitchell S. Cairo been licensed in?

Dmand AI has state licenses on file for Dr. Cairo in New York (2000 to 2025), California (1977 to 2026), Florida (2021 to 2023), District of Columbia (1998 to 2004) and Indiana (1979 to 1982).

Which hospitals is Dr. Mitchell S. Cairo affiliated with?

Dr. Cairo practices at Westchester Medical Center in Valhalla, New York.

What medical group is Dr. Mitchell S. Cairo part of?

Dr. Cairo is linked to Boston Children's Health Physicians.

Is Dr. Mitchell S. Cairo board certified?

Yes. Dr. Cairo is board certified in pediatric hematology-oncology by the American Board of Pediatrics.

Where did Dr. Mitchell S. Cairo go to medical school?

Dr. Cairo graduated from UCSF School of Medicine in 1976.

Show 5 more questionsShow fewer questions

Has Dr. Mitchell S. Cairo received payments from drug or device companies?

CMS Open Payments shows $1,364,390 in general payments to Dr. Cairo from 29 companies from 2016 to 2025. The largest total came from Jazz Pharmaceuticals Inc.

How long has Dr. Mitchell S. Cairo been practicing?

Dr. Cairo graduated from medical school in 1976, 50 years ago.

Does Dr. Mitchell S. Cairo do research?

Dmand AI links 324 publications to Dr. Cairo, published from 2003 to 2025. Dr. Cairo has worked on 40 clinical trials.

Who does Dr. Mitchell S. Cairo publish with?

Dr. Cairo's most frequent co-authors are Prakash Satwani, MD (31 shared papers), James Garvin (27 shared papers) and Monica Bhatia (25 shared papers).

What insurance does Dr. Mitchell S. Cairo accept?

Dr. Cairo is in network with 11 carriers, including MVP Health Care, United Healthcare and Elevance. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.

Selling to pediatric hematology-oncology practices?

See pediatric hematologys and oncology physicians in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)